Phase 2: a dose-escalation study of OncoGel (ReGel/paclitaxel), a controlled-release formulation of paclitaxel, as adjunctive local therapy to external-beam radiation in patients with inoperable esophageal cancer-Reference-Cited by-同舟云学术

Phase 2: a dose-escalation study of OncoGel (ReGel/paclitaxel), a controlled-release formulation of paclitaxel, as adjunctive local therapy to external-beam radiation in patients with inoperable esophageal cancer

Published:2009-02 Issue:2 Volume:20 Page:89-95
ISSN:0959-4973
Container-title:Anti-Cancer Drugs
language:en
Short-container-title:

Author:

Aaron DuVall G.,Tarabar Dino,Seidel Richard H.,Elstad Nancy L.,Fowers Kirk D.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Pharmacology (medical),Pharmacology,Oncology

Reference16 articles.

1. Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world;Kamangar;J Clin Oncol,2006

2. Paclitaxel in the treatment of esophageal cancer;Weiner;Semin Oncol,1999

3. Preoperative chemoradiotherapy for oesophageal cancer: a systematic review and meta-analysis;Fiorica;Gut,2004

4. Phase II trial of paclitaxel, fluorouracil, and cisplatin in patients with advanced carcinoma of the esophagus;Ilson;J Clin Oncol,1998

5. Chemoradiotherapy of esophageal cancer;Albertsson;Acta Oncol,2002

Cited by 69 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Harnessing the potential of hydrogels for advanced therapeutic applications: current achievements and future directions;Signal Transduction and Targeted Therapy;2024-07-01

2. Versatile tissue‐injectable hydrogels capable of the extended hydrolytic release of bioactive protein therapeutics;Bioengineering & Translational Medicine;2024-04-15

3. Innovative strategies for effective paclitaxel delivery: Recent developments and prospects;Journal of Oncology Pharmacy Practice;2024-01-10

4. Liposomes Affect Protein Release and Stability of ITA-Modified PLGA–PEG-PLGA Hydrogel Carriers for Controlled Drug Delivery;Biomacromolecules;2023-12-22

5. Versatile Tissue-Injectable Hydrogels with Extended Hydrolytic Release of Bioactive Protein Therapeutics;2023-09-02